2021
DOI: 10.1016/s1470-2045(20)30753-1
|View full text |Cite
|
Sign up to set email alerts
|

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

10
182
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 291 publications
(195 citation statements)
references
References 34 publications
10
182
3
Order By: Relevance
“…The advantages of 3D image-based brachytherapy are not only limited to dose distribution, including central hot spots and rapid dose fall-off, but also in the delivery of treatment with no setup margin. This has resulted in excellent outcomes, as seen in a recently published EMBRACE 1 study with 5-year local control of 92% (95% CI 90–93) and low grade 3 and above morbidities [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…The advantages of 3D image-based brachytherapy are not only limited to dose distribution, including central hot spots and rapid dose fall-off, but also in the delivery of treatment with no setup margin. This has resulted in excellent outcomes, as seen in a recently published EMBRACE 1 study with 5-year local control of 92% (95% CI 90–93) and low grade 3 and above morbidities [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…Bladder cancer is well suitable for ART since the bladder has large interfractional changes and intra-fractional motion (144,145). MRIguided adaptive brachytherapy in cervical cancer (146,147) and primary vaginal cancer (148) results in effective and stable longterm local control at all stages of cervical cancer, while decreasing severe radiation-induced morbidity. Similarly, promising results are also observed in liver tumors (149), prostate cancer (150), and unresectable primary malignancies of the abdomen.…”
Section: Adaptive Radiation Therapymentioning
confidence: 99%
“…For patients with locally advanced cervical cancer (LACC) treatment currently consists of concurrent (chemo) radiotherapy (CCRT) and image-guided adaptive 3D brachytherapy (IGABT) resulting in excellent local control and acceptable survival rates (1)(2)(3)(4). However, nodal failure (NF) remains challenging (5).…”
Section: Introductionmentioning
confidence: 99%